Concomitant use of tramadol and venlafaxine - evaluation of antidepressant-like activity and other behavioral effects in rats.
Journal Title: Pharmacological Reports - Year 2012, Vol 64, Issue 6
Abstract
The aim of this study was to evaluate antidepressant-like effect (Porsolt test), locomotor activity and motor coordination of joint administration of tramadol (TRM) and venlafaxine (VEN) in rats.
Authors and Affiliations
Danuta Szkutnik-Fiedler, Krzysztof Kus, Monika Balcerkiewicz, Edmund Grześkowiak, Elżbieta Nowakowska, Kinga Burda, Piotr Ratajczak, Czesław Sadowski
Keywords
Related Articles
- EP ID EP140990
- DOI -
- Views 82
- Downloads 0
Prostacyclin, but not nitric oxide, is the major mediator of acetylcholine-induced vasodilatation in the isolated mouse heart.
In many species, acetylcholine (Ach) induces coronary vasodilatation via endothelium-derived nitric oxide (NO). The aim of the present study was to examine if this rule pertains also to the coronary circulation of the mo...
Effects of olanzapine and paroxetine on phospholipase D activity in the rat brain.
Background: Phospholipase D (PLD) plays a key role in a second messenger system producing phosphatidic acid, mediating, among others, serotonin 5-HT2 receptor activity. The aim of the study was to evaluate a possible eff...
Baclofen influences acquisition and MMP-2, MMP-9 levels in the hippocampus of rats after hypoxia.
Background: Baclofen, the agonist of GABA(B) receptors, influences hypoxia-induced deficits in learning and memory processes. Methods: We studied the effects of baclofen on acquisition in the passive avoidance test and i...
Effect of cyclophosphamide and morin-5'-sulfonic acid sodium salt, alone or in combination, on ADMA/DDAH pathway in rats.
Background: The aim of the study was to evaluate the effect of cyclophosphamide (CPX) and morin-5'-sulfonic acid sodium salt (NaMSA) on plasma asymmetric dimethylarginine (ADMA) level and dimethylarginine dimethylaminohy...
Inhibition of NAD(P)H oxidase attenuates aggregation of platelets from high-risk cardiac patients with aspirin resistance.
Up to one-third of serious vascular events in high-risk patients is attributable to a failure of aspirin (ASA) to suppress platelet aggregation. We hypothesized that inhibition of NAD(P)H oxidase may inhibit aggregation...